Cargando…

Short-term prophylaxis (STP) with plasma derived human C1 inhibitor concentrate (pdhC1-INH) in two pregnant women with hereditary angioedema (HAE): an experience in Rio de Janeiro – Brazil

Detalles Bibliográficos
Autores principales:	Valle, Solange Oliveira Rodrigues, Oliva Alonso, Maria Luiza, Dortas, Sérgio Duarte, Levy, Soloni Afra Pires, Coutinho Millet, Ana Paula Ferracciú, França, Alfeu Tavares, De Carvalho, Ana Luiza Ribeiro Bard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406214/ http://dx.doi.org/10.1186/1939-4551-8-S1-A127

Ejemplares similares

Analysis of the prevalence of subtypes of angioedema without urticaria in a reference center in Rio de Janeiro – Brazil
por: Fernandes, Renata Silva, et al.
Publicado: (2015)

Omalizumab in chronic spontaneous urticaria (CSU): experience in three cases
por: Valle, Solange Oliveira Rodrigues, et al.
Publicado: (2015)

Autoimmune progesterone dermatitis (AIPD) triggered by intrauterine device (IUD): case report
por: Bard De Carvalho, Ana Luiza Ribeiro, et al.
Publicado: (2015)

A patient with hereditary angioedema (HAE) with normal C1-INH and SLE with pregnancy
por: Taha, Omar S., et al.
Publicado: (2022)

Drug rash induced by levothyroxine and oral desensitization
por: Dortas, Sérgio Duarte, et al.
Publicado: (2015)

Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE)
por: Parsopoulou, Faidra, et al.
Publicado: (2022)

SERPING1 Variants and C1-INH Biological Function: A Close Relationship With C1-INH-HAE
por: Drouet, Christian, et al.
Publicado: (2022)

Obesity: an asthma aggravating factor?
por: Filho, José Elabras, et al.
Publicado: (2015)

Individual approach to long-term therapy in patients with hereditary angioedema (HAE-C1-INH): A case series
por: Andarawewa, S., et al.
Publicado: (2022)

Impact of chronic urticaria on the quality of life of patients followed up at a university hospital
por: Dias, Gabriela Andrade Coelho, et al.
Publicado: (2016)

Psychometric study of the SF-36v2 in hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE)
por: Palao-Ocharan, Paola, et al.
Publicado: (2022)

Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis
por: da Cunha, Fernanda Sales, et al.
Publicado: (2018)

Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study()
por: Grumach, Anete S., et al.
Publicado: (2022)

Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE
por: Andarawewa, Shimalee, et al.
Publicado: (2021)

Chronic urticaria: profile from a reference center()
por: de Souza, Ana Carolina Miranda Carvalho Ferreira Fernandes, et al.
Publicado: (2022)

Systemic nickel allergy syndrome
por: Da Mata Perez, Luciana, et al.
Publicado: (2015)

The symptom experience of hereditary angioedema (HAE) patients beyond HAE attacks: literature review and clinician interviews
por: Jean-Baptiste, Milenka, et al.
Publicado: (2022)

Icatibant, an inhibitor of bradykinin receptor 2, for hereditary angioedema attacks: prospective experimental single-cohort study
por: Campos, Regis Albuquerque, et al.
Publicado: (2014)

Staphylococcal superantigen-specific IgE antibodies and its correlation with asthma severity
por: Filho, José Elabras, et al.
Publicado: (2015)

Hereditary angioedema with C1 inhibitor (C1-INH) deficit: the strength of recognition (51 cases)
por: Fragnan, N.T.M.L., et al.
Publicado: (2018)

Effectiveness of C1-INH therapy in angiotensin converting enzyme inhibitor induced angioedema
por: Kovaltchouk, Uliana, et al.
Publicado: (2021)

Brazilian guidelines for the diagnosis and treatment of hereditary angioedema
por: Giavina-Bianchi, Pedro, et al.
Publicado: (2011)

Clinical and genetic features of hereditary angioedema with and without C1‐inhibitor (C1‐INH) deficiency in Japan
por: Hashimura, Chinami, et al.
Publicado: (2021)

Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age
por: Hsu, Florence Ida, et al.
Publicado: (2022)

Hereditary angioedema: quality of life in Brazilian patients
por: Gomide, Maria Abadia Consuelo M S, et al.
Publicado: (2013)

Hereditary angioedema (HAE) in children and adolescents—a consensus on therapeutic strategies
por: Wahn, V., et al.
Publicado: (2012)

Cost-effectiveness model for on-demand treatment of hereditary angioedema (HAE) attacks
por: Tyson, Christopher, et al.
Publicado: (2019)

Hereditary angioedema (HAE) in Belgium: results from a national survey
por: Van der Poorten, MM, et al.
Publicado: (2023)

HBV suppresses macrophage immune responses by impairing the TCA cycle through the induction of CS/PDHC hyperacetylation
por: Bei, Jiaxin, et al.
Publicado: (2023)

Staphylococcal superantigen-specific IgE antibodies: degree of sensitization and association with severity of asthma
por: Elabras, José, et al.
Publicado: (2016)

Correction: Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age
por: Hsu, Florence Ida, et al.
Publicado: (2022)

Long-term Prophylaxis with Androgens in the management of Hereditary Angioedema (HAE) in emerging countries
por: Guo, Yinshi, et al.
Publicado: (2022)

Prevention of Recurrent Attacks of Hereditary Angioedema (HAE): Berotralstat and Its Oral Bioavailability
por: Diaz-Menindez, Maximiliano, et al.
Publicado: (2023)

A Case of Acquired Angioedema with Low C1 Inhibitor (C1-INH) Associated with Splenic Marginal Zone Lymphoma
por: Abdel-Samad, Nizar N., et al.
Publicado: (2019)

Treatment of hereditary angioedema with recombinant human C1 Inhibitor in a real-life setting: the experience of the HAE Centre in Milan
por: Zanichelli, Andrea, et al.
Publicado: (2015)

COVID-19 affecting hereditary angioedema patients with and without C1 inhibitor deficiency
por: Grumach, Anete S., et al.
Publicado: (2021)

The hereditary angioedema burden of illness study in Europe (HAE-BOIS-Europe): background and methodology
por: Bygum, Anette, et al.
Publicado: (2012)

Lanadelumab Injection Treatment For The Prevention Of Hereditary Angioedema (HAE): Design, Development And Place In Therapy
por: Bova, Maria, et al.
Publicado: (2019)

83 Hereditary Angioedema and Normal C1-Inhibitor (HAE TYPE III): A Novel Mutation in the Coagulation Factor 12 Gene
por: Bork, Konrad, et al.
Publicado: (2012)

COVID-19 triggers attacks in HAE patients without worsening disease outcome
por: Olivares, María Margarita, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mm867bvaa72ic06567rh1sklmg